CEACAM5 and neoplasm: (105), combined IL-6, IL-8, and TNF measurements with carcinoembryonic antigen (CEA) and cancer antigen (CA)-724, to improve the screening power of these two tumor markers, as detection rate at early stages of gastric cancer is still very low.